Ticker

No recent analyst price targets found for UWM.

Latest News for UWM

Stockholder Alert: Robbins LLP Informs Investors of the Aardvark Therapeutics, Inc. (UWM) Class Action

SAN DIEGO--(BUSINESS WIRE)---- $AARD #Health--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) (a) common stock pursuant to the Company's February 13, 2025 initial public offering ("IPO") and/or (b) securities between February 13, 2025 and May 14, 2026 (the…

Business Wire • Aug 14, 2026
Stockholder Alert: Robbins LLP Informs Investors of the UWM Holdings Corporation (UWM) Class Action

SAN DIEGO--(BUSINESS WIRE)---- $UWMC #Finance--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired UWM Holdings Corporation (NYSE: UWMC) securities between March 9, 2026 and August 5, 2026 (the "Class Period"). UWM engages in the origination, sale, and servicing of residential mortgage loans in the United…

Business Wire • Aug 14, 2026
UWM: Why Common Shareholders Must Now Wait Before Any Recovery

Walk through the cascade of pressures on the mortgage industry and UWMC: elevated rates, 10b5-1 selling plan, and a $603 million hedge loss tied to the failed Two Harbors deal that's driven the stock down nearly 70% YTD. The core business remained profitable underneath the Q2 loss, but the over-hedged derivatives and subsequent Oaktree Capital preferred raise have left common shareholders like myself with a much…

Seeking Alpha • Aug 11, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for UWM.

No Senate trades found for UWM.

No House trades found for UWM.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top